Contributing Author: Gina Hagler These five biotechnology companies in Maryland may make history in 2021 because they have multiple therapeutic programs in trials for a variety of genetic diseases. REGENXBIO is a publicly-traded company that develops products for one-and-done, single-dose solutions addressing genetic defects. Their products use adeno associated virus (AAV) viral vectors that make up their proprietary NAV Technology… [Read More]
Conventional vaccine development can take many years, yet vaccines targeting the novel coronavirus were approved and began distribution in under 12 months. Pfizer, Moderna, and AstraZeneca have led the race, announcing promising interim results in their vaccine trials, with Pfizer’s and Moderna’s vaccines showing upwards of 90% effectiveness. The news is filled with updates on the progress of these vaccines,… [Read More]
TED Talks began in 1984 as a conference originating in Silicon Valley where powerful voices in Technology, Entertainment, and Design came together to spread potent ideas with broad relevance. Today there are thousands of talks of 18 minutes or less, in more than 100 languages, covering topics ranging from science to global issues. Despite this diversity, all TED talks share… [Read More]
Written by Jeff Galvin, CEO of American Gene Technologies The birth of high-value therapeutics and cures Does the development of effective drugs have to be incredibly expensive? Maybe not anymore. There is a new type of drug development emerging: Gene Therapy. The hallmark of gene therapy is the ability to edit or modify the drivers of disease at the most fundamental… [Read More]
There have been historic moments in scientific research that have gone unnoticed. Often we don’t hear about these scientific discoveries until they are ready to be unveiled to the rest of the world. However, listed below are four scientific breakthroughs that you may not yet know about and should. These discoveries not only shape our future and advanced science… [Read More]
Today the world celebrated the second patient cured of HIV. The work of Ravindra Gupta teaches us lessons not only of the potential for an HIV cure in the future, but how that cure may function. While a bone marrow transplant is not a practical way to cure HIV in most patients, the mechanism of action likely holds the key… [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!